EcoDrugPlus

Prostaglandin I2 Receptor

Ensembl ID : ENSCMIG00000010647
Gene Symbol: PTGIR
3 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSCMIG00000014238
Gene Symbol: PTGS1
4 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSCMIG00000017023
Gene Symbol: PTGS2
4 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSCMIG00000014469
Gene Symbol: PSMA1
3 Cross references
271 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSCMIG00000001454
Gene Symbol: PSMA2
3 Cross references
293 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCMIG00000001027
Gene Symbol: PSMA3
3 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSCMIG00000002803
Gene Symbol: PSMA5
3 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSCMIG00000002150
Gene Symbol: PSMA6
3 Cross references
309 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSCMIG00000015296
Gene Symbol: PSMA7
3 Cross references
158 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSCMIG00000004051
Gene Symbol: PSMA8
3 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSCMIG00000003637
Gene Symbol: PSMB1
4 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSCMIG00000006267
Gene Symbol: PSMB2
3 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).